Substance Withdrawal Syndrome Clinical Trial
Official title:
Validation of a Pediatric Abstinence Syndrome Scoring Tool Utilizing a Standardized Hospital-Based Guideline for Iatrogenic Opioid Dependence
The purpose of this study is to assess the validity and reliability of an abstinence syndrome assessment tool used in pediatric patients with iatrogenic opioid dependence.
| Status | Recruiting |
| Enrollment | 75 |
| Est. completion date | December 2010 |
| Est. primary completion date | April 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | N/A to 18 Years |
| Eligibility |
Inclusion Criteria: - Pediatric Intensive Care Unit patients ages 2 weeks to 18 years - Patients receiving continuous opioid infusions for 5 days (at least 120 hours) or more Exclusion Criteria: - Attending discretion - Patients with deterioration of medical status requiring interventions of pain control, surgery, sedation, or re-intubation |
Observational Model: Cohort, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| United States | Cardon Children's Medical Center | Mesa | Arizona |
| Lead Sponsor | Collaborator |
|---|---|
| Banner Health |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Total scores of abstinence syndrome symptoms | Up to 23 days | No | |
| Secondary | Expert opinion on abstinence syndrome | Up to 23 days | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00114439 -
Lithium Cannabis Withdrawal Study
|
Phase 2 | |
| Completed |
NCT00980044 -
Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
|
Phase 2/Phase 3 | |
| Completed |
NCT02643355 -
Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
|
N/A | |
| Completed |
NCT02782156 -
Process Evaluation Standardised Nurse-led Approach for Risk Screening and Decrease of Alcohol Withdrawal in ENT
|
N/A | |
| Completed |
NCT02431728 -
The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program
|
Phase 1/Phase 2 | |
| Completed |
NCT00695864 -
Effect of Ondansetron for Withdrawal Symptoms
|
N/A | |
| Active, not recruiting |
NCT02951793 -
Abuse and Addiction in ICU
|
||
| Completed |
NCT02108626 -
Electronic Cigarettes in Daily Dependent Smokers
|
Phase 4 | |
| Recruiting |
NCT04917185 -
EA for PAAS: A pRCT
|
N/A | |
| Completed |
NCT02801357 -
Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
|
Phase 1 | |
| Completed |
NCT01362959 -
Nicotine Replacement Therapy in the Intensive Care Unit
|
Phase 4 | |
| Completed |
NCT00992979 -
Therapeutic Massage to Manage Withdrawal Related Anxiety
|
Phase 2 | |
| Completed |
NCT02825459 -
Does Abstinence From E-cigarettes Produce Withdrawal Symptoms?
|
N/A | |
| Completed |
NCT00900900 -
The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers
|
Phase 2 | |
| Completed |
NCT02318290 -
Opioids Withdrawal Syndrome in Critically Ill Patients: a Multicenter Prospective Cohort Study
|
N/A | |
| Completed |
NCT00032968 -
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
|
Phase 3 | |
| Completed |
NCT03374722 -
Opioid Withdrawal Symptoms in Critically Ill Patients
|
||
| Completed |
NCT03435614 -
Signs and Symptoms of Opioid-associated Iatrogenic Withdrawal in Critically Ill Adults
|
||
| Completed |
NCT00570219 -
The Effect of Valproate on Benzodiazepine Withdrawal Severity
|
N/A | |
| Completed |
NCT00367874 -
Treatment of Polydrug-Using Opiate Dependents During Withdrawal
|
Phase 4 |